118 related articles for article (PubMed ID: 11080538)
1. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus.
Addison WR; Wong WW; Fischer KP; Tyrrell DL
Antiviral Res; 2000 Oct; 48(1):27-37. PubMed ID: 11080538
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver.
Zhang YY; Zhang BH; Theele D; Litwin S; Toll E; Summers J
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12372-7. PubMed ID: 14528003
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of a method to detect duck hepatitis B virus covalently closed circular DNA based on rolling circle amplification].
Su HL; Wang HM; Ran JY; Wang Z; Li HY; Yang Y; Xu DP; Liu YM
Bing Du Xue Bao; 2014 Jul; 30(4):382-6. PubMed ID: 25272590
[TBL] [Abstract][Full Text] [Related]
4. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
5. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
[TBL] [Abstract][Full Text] [Related]
6. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication.
Addison WR; Walters KA; Wong WW; Wilson JS; Madej D; Jewell LD; Tyrrell DL
J Virol; 2002 Jun; 76(12):6356-63. PubMed ID: 12021368
[TBL] [Abstract][Full Text] [Related]
7. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
Lenhoff RJ; Luscombe CA; Summers J
Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
[TBL] [Abstract][Full Text] [Related]
8. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.
Köck J; Rösler C; Zhang JJ; Blum HE; Nassal M; Thoma C
PLoS Pathog; 2010 Sep; 6(9):e1001082. PubMed ID: 20824087
[TBL] [Abstract][Full Text] [Related]
9. Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes.
Shi L; Li S; Shen F; Li H; Qian S; Lee DH; Wu JZ; Yang W
J Virol; 2012 Sep; 86(18):10059-69. PubMed ID: 22787202
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.
Singh M; Dicaire A; Wakil AE; Luscombe C; Sacks SL
J Virol Methods; 2004 Jun; 118(2):159-67. PubMed ID: 15081611
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection.
Thermet A; Buronfosse T; Werle-Lapostolle B; Chevallier M; Pradat P; Trepo C; Zoulim F; Cova L
J Gen Virol; 2008 May; 89(Pt 5):1192-1201. PubMed ID: 18420797
[TBL] [Abstract][Full Text] [Related]
12. Development and application of a universal Taqman real-time PCR for quantitation of duck hepatitis B virus DNA.
Wang Y; Li Y; Yang C; Hui L; Han Q; Ma L; Wang Q; Yang G; Liu Z
J Virol Methods; 2013 Jul; 191(1):41-7. PubMed ID: 23557670
[TBL] [Abstract][Full Text] [Related]
13. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.
Turin F; Borel C; Benchaib M; Kay A; Jamard C; Guguen-Guillouzo C; Trépo C; Hantz O
J Virol; 1996 May; 70(5):2691-6. PubMed ID: 8627742
[TBL] [Abstract][Full Text] [Related]
14. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
Saade F; Buronfosse T; Guerret S; Pradat P; Chevallier M; Zoulim F; Jamard C; Cova L
J Viral Hepat; 2013 Apr; 20(4):e56-65. PubMed ID: 23490390
[TBL] [Abstract][Full Text] [Related]
15. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
Lenhoff RJ; Luscombe CA; Summers J
Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
[TBL] [Abstract][Full Text] [Related]
16. [Effects of hyperin on the cccDNA of duck hepatitis B virus and its immunological regulation].
Geng M; Wang JH; Chen HY; Yang XB; Huang ZM
Yao Xue Xue Bao; 2009 Dec; 44(12):1440-4. PubMed ID: 21351483
[TBL] [Abstract][Full Text] [Related]
17. Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.
Narayan R; Buronfosse T; Schultz U; Chevallier-Gueyron P; Guerret S; Chevallier M; Saade F; Ndeboko B; Trepo C; Zoulim F; Cova L
J Gen Virol; 2006 Nov; 87(Pt 11):3225-3232. PubMed ID: 17030856
[TBL] [Abstract][Full Text] [Related]
18. Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor.
Yang W; Summers J
J Virol; 1999 Dec; 73(12):9710-7. PubMed ID: 10559280
[TBL] [Abstract][Full Text] [Related]
19. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.
Reaiche-Miller GY; Thorpe M; Low HC; Qiao Q; Scougall CA; Mason WS; Litwin S; Jilbert AR
Virology; 2013 Nov; 446(1-2):357-64. PubMed ID: 24074600
[TBL] [Abstract][Full Text] [Related]
20. Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA.
Chen YX; Huang AL; Qi ZY; Guo SH
World J Gastroenterol; 2004 Sep; 10(18):2666-9. PubMed ID: 15309716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]